top of page

Search Results

Results found for "Robert J Lefkowitz"

  • 📰 GPCR Weekly News, July 10 to 16, 2023

    Robert J Lefkowitz. Join us tomorrow, July 21, in the Dr.

  • 📰 GPCR Weekly News, September 11 to 17, 2023

    Robert Lefkowitz on his 50 years at Duke. Congratulations. Dr. leukotriene G-protein coupled receptors Industry News Duke University Celebrates Nobel Prize Winner Robert Lefkowitz’s 50 Years of Scientific Discovery Novo Nordisk Foundation Grants Fuel Exciting GPCR and Signaling J. Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting

  • 📰 GPCR Weekly News, October 16 to 22, 2023

    Robert J Lefkowitz and team's study 'GPCR signal transduction: ÎČ-arrestin activates ERK MAPK.' Dr. J. Silvio Gutkind.

  • 📰 GPCR Weekly News, September 25 to October 1, 2023

    Michel Bouvier, J Silvio Gutkind, and team found that Gαs is essential for GRK selectivity and gene regulation gap in cardiometabolic diseases GPCR Events, Meetings, and Webinars October 2 - 3, 2023 | Celebrating Robert J. Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting

  • 📰 GPCR Weekly News, September 18 to 24, 2023

    Deadline September 27, 2023 GPCR Events, Meetings, and Webinars October 2 - 3, 2023 | Celebrating Robert J. Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting

  • 📰 GPCR Weekly News, April 8 to 14, 2024

    Kozielewicz, et al. for their study on Frizzleds act as dynamic pharmacological entities Marina Casiraghi, Robert J Lefkowitz, Peter Gmeiner, Brian K Kobilka et al. for their investigation on Molecular insights into

  • Dr. Nicola J. Smith - Dr. GPCR Podcast

    Next on the Dr. GPCR Podcast, we have Dr. Nicola Smith, Molecular Pharmacologist, lab head, and senior lecturer at UNSW Sydney. Subscribe to the podcast today and get notified when new episodes are released! Please share! https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #gpcr #drgpcr #podcast

  • Exscientia welcomes Richard J. Law, as their new Chief Business Officer

    March 2022 "Congratulations to Richard J. Law, our newly named Chief Business Officer.

  • Dr. Peter Robert Banks - Dr. GPCR Podcast

    Ep 57 of the Dr. GPCR podcast is now available! Our guest is Dr. Peter Banks, Scientific Director at BioTek Instruments! Learn about his career today! Listen where you get your podcasts. https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #gpcr #drgpcr #podcast

  • Ode to GPCRs

    relevant to GPCR-mediated signaling was the 2012 Nobel Prize in Chemistry to Brian Kent Kobilka and Robert Joseph Lefkowitz for their work on GPCR function.[62–66] Lefkowitz was able to isolate ÎČ-adrenergic Later on, Kobilka joined in with Lefkowitz to identify the shared architecture of the ÎČ-adrenergic receptor Robert J. Lefkowitz – Facts - NobelPrize.org. https://www.nobelprize.org/prizes/chemistry/2012/lefkowitz/facts/

  • From DNA day to GPCR genomics

    discovery and sequencing of the beta-adrenergic receptor (ÎČAR), the first GPCR to be identified by Robert Lefkowitz and colleagues during their study of the effects of adrenaline on cells2. J., Benovic, J. L., Dohlman, H. G., Frielle, T., Bolanowski, M. A., Bennett, C. G., Lefkowitz, R. J., & Strader, C. D. (1986).

  • 📰 GPCR Weekly News, July 31 to August 6, 2023

    Nichola J Smith's investigation: Gene expression of TAS1R taste receptors for cardiometabolic disease Robert Lefkowitz Lab Postdoc Fellow - Dr. Robert Lefkowitz Lab Senior Research Specialist - Natural Sciences - Surgery Senior Scientist- Membrane

  • 📰 GPCR Weekly News, August 7 to 13, 2023

    Robert Lefkowitz Lab Postdoc Fellow - Dr. Robert Lefkowitz Lab Explore Dr. GPCR Ecosystem

  • Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with ...

    The company's co-founder, GPCR pioneer and Nobel laureate Robert Lefkowitz, M.D., has 50 years of experience

  • Unlocking Cell's Secrets: Spontaneous ÎČ-Arrestin-Membrane Preassociation Drives Receptor-Activation

    M., Medel-Lacruz, B., Baidya, M., Makarova, M., Mistry, R., Goulding, J., Drube, J., Hoffmann, C., Owen K., Selent, J., Hill, S. J., & Calebiro, D. (2023). Cell, 186(10), 2238–2255.e20. https://doi.org/10.1016/j.cell.2023.04.018 Janetzko, J., Kise, R., Barsi-Rhyne Nature 557, 452–456. https://doi.org/10.1038/s41586-018-0077-3 Pierce, K.L., and Lefkowitz, R.J. (2001 Reiter, E., Ahn, S., Shukla, A.K., and Lefkowitz, R.J. (2012).

  • 📰 GPCR Weekly News, July 17 to July 23, 2023

    Robert Lefkowitz Lab NEW Postdoc Fellow - Dr. Robert Lefkowitz Lab Senior Research Specialist - Natural Sciences - Surgery Senior Scientist- Membrane

  • 📰 GPCR Weekly News, July 24 to July 30, 2023

    Robert Lefkowitz Lab Postdoc Fellow - Dr. Robert Lefkowitz Lab Senior Research Specialist - Natural Sciences - Surgery Senior Scientist- Membrane

  • An overview of the compartmentalized GPCR Signaling: Relevance and Implications

    S., Sousa, J. B., Gonçalves, J., & Diniz, C. (2019). N., Castro, M., Wang, B., Bouley, R., Potts, J. T., Gardella, T. J., & Vilardaga, J. P. (2009). M., & Lefkowitz, R. J. (2003). J., & Calebiro, D. (2016). J., & Calebiro, D. (2017).

  • The Perils and Guardrails of Modifying Signalling Proteins in Bioassays

    Wouters OJ, McKee M, Luyten J. J Health Econ. 2016;47:20-33. 8.            Liu S, Anderson PJ, Rajagopal S, Lefkowitz RJ, Rockman HA. Lu S, He X, Ni D, Zhang J. Changeux J-P, Christopoulos A.

  • Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery

    J. (2019). Volmat, V., & Pouysségur, J. (2001). Spatiotemporal regulation of the p42/p44 MAPK pathway. M., & Lefkowitz, R. J. (2003).

  • Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery

    Reference   Bikker, J. A., Trumpp-Kallmeyer, S., & Humblet, C. (1998). Carlsson, J., Yoo, L., Gao, Z. G., Irwin, J. J., Shoichet, B. K., & Jacobson, K. A. (2010). Di Roberto, R. B., Chang, B., & Peisajovich, S. G. (2017). T., Baltos, J.-A., Thomas, T., Nguyen, T. D., Muñoz, L. L., Gregory, K. J., White, P. J., Sexton, P. M., Christopoulos, A., & May, L. T. (2016).

  • A2A Fluorescent Competitive Binding: Advancing NanoBRETÂź Target Engagement for GPCR Drug Discovery

    J.; Goulding, J.; Robers, M. B.; Machleidt, T.; Wood, K. V.; Hill, S. J.; Pfleger, K. D. G. J. Med. Chem. 2000, 43 (23), 4359–4362. https://doi.org/10.1021/jm0009843 . (4) Jacobson, K. T.; Carlsson, J. Adenosine A2A Receptor Antagonists: From Caffeine to Selective Non‐xanthines. British J Pharmacology 2022, 179 (14), 3496–3511. https://doi.org/10.1111/bph.15103 . (5) Borrmann, T J. Med. Chem. 2009, 52 (13), 3994–4006. https://doi.org/10.1021/jm900413e . (6) Klotz, K.-N.

  • A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.

    .; Tuisku, J. M.; Hirvonen, J. E. S.; Vahlberg, T.; Lahdenpohja, S.; Rinne, J. O.; BrĂŒck, A. E. J. Med. Der Wel, T.; Mandhair, H.; Honer, M.; Fingerle, J.; Scheffel, J.; Broichhagen, J.; Gawrisch, K.; Romero , J.; Hillard, C. .; HĂ©nichart, J.-P.

  • 📰 GPCR Weekly News, October 2 to 8, 2023

    ‘Define your own success’: Duke leaders talk success, failure at symposium honoring Nobel Laureate Robert Lefkowitz Integral Molecular Secures Nearly $900K in NIH Funding to Discover Antibodies Against Difficult

  • Conjugation Strategies for Probe Development

    .; Boström, J. J. Med. Chem.   2016 , 59  (10), 4443–4458. https://doi.org/10.1021/acs.jmedchem.5b01409 . .; Salvador Andresa, J.; Allongue, P.; Chazalviel, J.-N.; Gouget-Laemmel, A.   (3) Fan, J.; Toth, I.; Stephenson, R. J.

  • Nanobodies: New Dimensions in GPCR Signaling Research

    J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., Devree, B. T., Rosenbaum, D. M., Thian, F. H., Pautsch, A., Steyaert, J., Weis, W. I., & Kobilka, B. K. (2011). M., Manglik, A., Hu, J., Hu, K., Eitel, K., HĂŒbner, H., Pardon, E., Valant, C., Sexton, P. C., Gmeiner, P., Steyaert, J., Weis, W. I., Garcia, K. C., Wess, J., & Kobilka, B. K. (2013). Nature, 504(7478), 101–106. https://doi.org/10.1038/nature12735 Burg, J. S., Ingram, J.

  • 📰 GPCR Weekly News, February 26 to March 3, 2024

    Robert Lefkowitz for their work on GPCRs: from radioligand binding to cellular signaling Dr.

  • Fluorescence Polarization in GPCR Research

    Adapted from: Zhang Y, Tang H, Chen W, Zhang J. Int J Mol Sci. 2022 Aug 3;23(15):8625 . Miranda-Pastoriza D, Bernårdez R, Azuaje J, Prieto-Díaz R, Majellaro M, Tamhankar AV, Koenekoop L, Gonzålez A, Gioé-Gallo C, Mallo-Abreu A, Brea J, Loza MI, García-Rey A, García-Mera X, Gutiérrez-de-Terån H,

  • Illuminating C5aR Biology: The Role of Fluorescent Ligands in GPCR Research

    British J Pharmacology 2007 , 152 (4), 429–448. https://doi.org/10.1038/sj.bjp.0707332 . (4) BarbazĂĄn , J.; Majellaro, M.; Brea, J. https://doi.org/10.1016/j.biopha.2022.113408 . (5) RaĂŻch, I.; Rivas-Santisteban, R.; Lillo, A.; Lillo, J. 105970. https://doi.org/10.1016/j.phrs.2021.105970 . (6) Miranda-Pastoriza, D.; BernĂĄrdez, R.; Azuaje, J. V.; Koenekoop, L.; GonzĂĄlez, A.; GioĂ©-Gallo, C.; Mallo-Abreu, A.; Brea, J.; Loza, M.

  • Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research

    Int J Mol Sci. 2014 Feb 13;15(2):2554-72. Source: Navarro G, Sotelo E, RaĂŻch I, Loza MI, Brea J, Majellaro M. References Navarro G, Sotelo E, RaĂŻch I, Loza MI, Brea J, Majellaro M. Int J Mol Sci. 2014 Feb 13;15(2):2554-72. doi: 10.3390/ijms15022554.

bottom of page